Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
Two men accused of preparing to build a bomb for an attack in the UK will stand trial in June.
A mother-of-two was strangled by her partner in Halifax after she said to him: "I know what you're going to do, you're going to kill me".
Saturday looks like the best day for Sunshine. Some potential disruption on Sunday with difficult driving conditions.